Join
Live feed
·
PRReleasevia Quantisnow
Biogen Inc. logo
Ionis Pharmaceuticals Inc. logo

Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results

ByQuantisnow·Wall Street's wire, on your screen.
BIIB· Biogen Inc.IONS· Ionis Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIIB (Biogen Inc.), IONS (Ionis Pharmaceuticals Inc.) and more on Quantisnow.